These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18065125)

  • 1. RTOG clinical trials for prostate cancer.
    DeMare PA
    Hawaii Med J; 2007 Oct; 66(10):273-4, 276. PubMed ID: 18065125
    [No Abstract]   [Full Text] [Related]  

  • 2. A call for more with a desire for less: pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer.
    Pollack A
    J Clin Oncol; 2003 May; 21(10):1899-901. PubMed ID: 12743140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer].
    Bolla M; Fourneret P; Descotes JL
    Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile dysfunction after radiotherapy for prostate cancer.
    Mendenhall WM; Henderson RH; Indelicato DJ; Keole SR; Mendenhall NP
    Am J Clin Oncol; 2009 Aug; 32(4):443-7. PubMed ID: 19657239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
    Roach M
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():26-8. PubMed ID: 18167004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
    Dörr W; Jaal J; Zips D
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():14-5. PubMed ID: 18166999
    [No Abstract]   [Full Text] [Related]  

  • 7. Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy.
    Purdy JA; Harms WB; Michalski J; Cox JD
    Front Radiat Ther Oncol; 1996; 29():255-63. PubMed ID: 8742907
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail?
    Bellmunt J
    Eur Urol; 2009 Jun; 55(6):1310-2. PubMed ID: 18778888
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
    Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent androgen blockade should be regarded as standard therapy in prostate cancer.
    Seruga B; Tannock IF
    Nat Clin Pract Oncol; 2008 Oct; 5(10):574-6. PubMed ID: 18628739
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer.
    D'Amico AV
    J Clin Oncol; 2007 Jan; 25(1):8-9. PubMed ID: 17194901
    [No Abstract]   [Full Text] [Related]  

  • 13. Epothilones and the next generation of phase III trials for prostate cancer.
    Bhandari MS; Hussain M
    BJU Int; 2005 Aug; 96(3):296-302. PubMed ID: 16042717
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapies in development for castrate-resistant prostate cancer.
    Harzstark AL; Ryan CJ
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):259-68. PubMed ID: 18279066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conformal radiotherapy of prostatic cancer: a general review].
    Chauvet B; Oozeer R; Bey P; Pontvert D; Bolla M
    Cancer Radiother; 1999; 3(5):393-406. PubMed ID: 10572509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
    Nanda A; D'Amico AV
    BJU Int; 2008 Nov; 102(10):1366-8. PubMed ID: 18778343
    [No Abstract]   [Full Text] [Related]  

  • 20. Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.
    Bria E; Cuppone F; Giannarelli D; Milella M; Ruggeri EM; Sperduti I; Pinnarò P; Terzoli E; Cognetti F; Carlini P
    Cancer; 2009 Aug; 115(15):3446-56. PubMed ID: 19484790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.